News

15 Sep 2017

Visit REPROCELL Booth 107 at the SPS Annual Meeting, Berlin, 24-27 September 2017

Visit REPROCELL Booth 107 at the SPS Annual Meeting, Berlin, 24-27 September 2017
Read More >>

06 Sep 2017

Visit REPROCELL Booth A66 at Basel Life Science Week (MipTec), 11-13 September 2017

Basel Life Science Week this year will be held at Basel Congress Centre, Switzerland on 11-13 September 2017. REPROCELL will be at booth A66 at the MipTec Vendor Exhibition, located in Hall 4.1.
Read More >>

10 Aug 2017

PRESS RELEASE: Nicola Sturgeon, First Minister of Scotland, opens REPROCELL European Headquarters in Glasgow

REPROCELL Europe Ltd (REPROCELL), a leading provider of products and services for research in stem cells, drug discovery, human tissues and 3D cell culture and a member of the REPROCELL Group, has opened its European headquarters in Glasgow, UK.
Read More >>

10 Aug 2017

Nicola Sturgeon: interview at the official opening of REPROCELL's Centre for Predictive Drug Discovery (YouTube video)

First Minister Nicola Sturgeon officially opened the new European headquarters of a life sciences company which is set to generate 15 new jobs and safeguard a further three following new investment.
Read More >>

1 2 3 4 >>

Human Tissue Experts REPROCELL Launch New Customized Primary Cell Isolation Services

21/06/2018

REPROCELL’s BioServe and Biopta tissue procurement networks combine to create a new service isolating human primary cells.

REPROCELL Human Tissue Networks

REPROCELL, the leading human tissue research company, is further expanding its range of human tissue services provided to the pharmaceutical industry. For over 16 years, its BioServe and Biopta brands have been recognized experts in accessing ethically-sourced human biospecimens. Through its new cell culture facilities in Maryland and Glasgow, UK, REPROCELL sources tissues and isolates primary cells from tissues including blood and solid tissues. REPROCELL can access both healthy donors and a wide range of diseases (e.g. COPD, Asthma, Psoriasis, Inflammatory bowel disease, etc.). REPROCELL has over 600,000 samples in its biorepository and also offers custom collections from its global tissue network.

 

Human primary cells: more relevant than animal cells or immortalized cell lines

We provide our clients with customized projects to generate primary cells of value to your research programs. By using human cells, important physiological properties of the original tissue are retained and the prediction of human responses to drugs is superior to tests using immortalized cell lines or animal cells.

 

Find out more »

 

Or contact info-emea@reprocell.com for more information and to talk about your requirements with our experts.


Chirag Tawde

Written by Chirag Tawde

Sales Director EMEA

Live chat by BoldChat